MindChild Medical Looks for FDA Approval

MBBP client MindChild Medical Inc. recently announced it has successfully completed filing of a Pre-Marketing Notification Application (510(k)) with the U.S. Food and Drug Administration for Meridian, a non-invasive fetal heart rate monitor. MindChild Medical expects the FDA to provide feedback on the 510(k) application in the next quarter, and also plans to begin marketing Meridian, based on expected approval, once it receives FDA clearance.

For more information, please see the full press release.